Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-19747 |
Brand: | MCE |
CAS: | 1429651-50-2 |
MDL | MFCD27952937 |
---|---|
Molecular Weight | 314.34 |
Molecular Formula | C17H18N2O4 |
SMILES | O=C(N(CCO)C1=CC=CC=C1)CC2=CC=C(C(NO)=O)C=C2 |
HPOB is a highly potent and selective inhibitor of HDAC6 with an IC 50 of 56 nM. HPOB displays >30 fold less potent against other HDACs. HPOB enhances the effectiveness of DNA-damaging anticancer agents in transformed cells but not normal cells. HPOB does not block the ubiquitin-binding activity of HDAC6 [1] .
HDAC6 0.056 μM (IC 50 ) |
HDAC3/NCOR2 1.7 μM (IC 50 ) |
HDAC8 2.8 μM (IC 50 ) |
HDAC1 2.9 μM (IC 50 ) |
HDAC10 3.0 μM (IC 50 ) |
HDAC2 4.4 μM (IC 50 ) |
HPOB (8, 16, or 32 μM; 72 hours) inhibits growth, however, not viability, of normal or transformed cells
[1]
.
In normal (HFS) and transformed (LNCAP, U87, and A549) cells, HPOB causes accumulation of acetylated α-tubulin and acetylated peroxiredoxin, substrates of HDAC6, but not of acetylated histones. HPOB enhances etoposide-, doxorubicin-, and SAHA-induced transformed cell ((LNCAP, U87, and A549 cells) death but not normal cell death
[1]
.
In LNCaP cells cultured with HPOB and etoposide, there was an increase in cleaved PARP, a marker of apoptosis. Combination of HPOB with etoposide increased the accumulation of DNA damage compared with etoposide alone as evidenced by accumulation of γH2AX in LNCaP cells
[1]
.
HPOB attenuates corticosterone-induced injury in rat adrenal pheochromocytoma PC12 cells by inhibiting mitochondrial GR translocation and the intrinsic apoptosis pathway
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay [1]
Cell Line: | Normal human foreskin fibroblast (HFS), LNCaP, A549, U87 cells |
Concentration: | 8, 16, or 32 μM |
Incubation Time: | 72 hours |
Result: | Inhibited cell growth of normal and transformed cells in a concentration-dependent manner but do not induce cell death of normal or transformed cells. |
HPOB (300 mg/kg; i.p.; daily for 18 days) and SAHA (50 mg/kg) causes suppression of the growth of established CWR22 tumors [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Nude mice (CWR22 human prostate cancer xenograf) [1] |
Dosage: | 300 mg/kg |
Administration: | I.p.; daily for 18 days |
Result: | Combination with SAHA showed significant shrinkage of CWR22 tumors. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 50 mg/mL ( 159.06 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.1813 mL | 15.9063 mL | 31.8127 mL |
5 mM | 0.6363 mL | 3.1813 mL | 6.3625 mL |
10 mM | 0.3181 mL | 1.5906 mL | 3.1813 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.